During postmenopausal osteoporosis, altered estrogen receptor (ER) signaling and reduced estradiol production disrupt bone homeostasis, leading to a decrease in osteoblasts and increased osteoclast activity [36]. The gene discussed is ESR1; the disease is postmenopausal osteoporosis.